Ropharma’s Worst Case Scenario Sees 15% Rise In Sales For 2012

11.09.2011 By Ioana David

Businessman Mihai Miron, who controls medicine wholesaler Ropharma (RPH.RO), with an annual turnover of around RON400 million (around EUR92 million), says he is working with two budget versions for next year’s revenues, and the pessimistic scenario refers to 15% growth, at the same pace as the market.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
ROPHARMA
, FORECAST
, SALES